Corpus Intelligence IC Memo — ALLEGIANCE BEHAVIORAL CTR OF PLAINVI 2026-04-26 13:47 UTC
IC Memo — ALLEGIANCE BEHAVIORAL CTR OF PLAINVI
Investment Committee Memorandum | TX | 20 beds | Grade D | EBITDA uplift $311K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ALLEGIANCE BEHAVIORAL CTR OF PLAINVI

CCN 454101 | HALE, TX | 20 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ALLEGIANCE BEHAVIORAL CTR OF PLAINVI is a 20-bed community hospital in HALE, TX with $4.1M in net patient revenue and a 0.9% operating margin. The hospital serves a payer mix of 55.5% Medicare, 0.0% Medicaid, and 44.5% commercial.

Thesis: Turnaround. Our ML models identify $311K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.9% to 8.6% (+768bps).

Net Revenue HCRIS$4.1M
Current EBITDA COMPUTED$37K
Operating Margin COMPUTED0.9%
Occupancy HCRIS52.2%
Revenue / Bed COMPUTED$203K
Net-to-Gross HCRIS53.9%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
220
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 0.9% places it above the state median. Among 220 size-comparable peers (10-40 beds), the median margin is -12.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (10-40), prioritizing same-state peers. 220 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ALLEGIANCE BEHAVIORAL CTR OF P (Target)TX20$4.1M0.9%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%
TEXAS SPINE AND JOINT HOSPITALTX20$147.3M30.3%
NORTH CENTRAL SURGICAL HOSPITATX24$143.6M32.0%
SCOTT AND WHITE HOSPITAL TAYLOTX25$139.7M-47.5%
BAYLOR SURGICAL HOSPITAL AT FOTX30$136.0M14.8%
BAYLOR ORTHOPEDIC AND SPINE HOTX24$133.8M39.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $311K (768bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$86K+213bp12mo
Net Collection Rate93.5%97.0%$85K+210bp18mo
Cost to Collect4.5%2.5%$81K+200bp12mo
A/R Days Reduction5200.0%3800.0%$49K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+24bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$86K
Net Collection Rate
$85K
Cost to Collect
$81K
A/R Days Reduction
$49K
Clean Claim Rate
$10K
Total EBITDA Uplift$311K
Current EBITDA$37K
+ RCM Uplift+$311K
Pro Forma EBITDA$348K
Current Margin0.9%
Pro Forma Margin8.6%
WC Released (1x)$155K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$57K$3.4M59.06x126.1%
Base (11x exit)10.0x11.0x$57K$3.7M65.29x130.7%
Bull Case9.0x11.0x$51K$4.8M92.99x147.6%
Bull (12x exit)9.0x12.0x$51K$5.2M101.74x152.1%
Bear Case11.0x10.0x$63K$1.8M28.50x95.4%
Bear (11x exit)11.0x11.0x$63K$2.0M31.67x99.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 55.5% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 220 hospitals with 10-40 beds
  • Same-state prioritization (n=221)
  • Comp margins: P25=-42.1% / P50=-12.4% / P75=8.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.